Literature DB >> 22362416

Hepatorenal syndrome: is it the magnitude of the renal failure that matters?

Marco A Olivera-Martínez, Marius C Florescu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22362416     DOI： 10.1007/s10620-012-2093-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

Review 1.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

Authors:  Francesco Salerno; Alexander Gerbes; Pere Ginès; Florence Wong; Vicente Arroyo
Journal:  Gut       Date:  2007-03-27       Impact factor: 23.059

2.  Hepatorenal syndrome: are we missing some prognostic factors?

Authors:  Marco Olivera-Martinez; Marco Olivera Martinez; Harlan Sayles; Renuga Vivekanandan; Sharlene D' Souza; Marius C Florescu
Journal:  Dig Dis Sci       Date:  2011-08-18       Impact factor: 3.199

3.  Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.

Authors:  Thomas D Boyer; Arun J Sanyal; Guadalupe Garcia-Tsao; Andres Blei; Daniel Carl; Alice S Bexon; Peter Teuber
Journal:  J Hepatol       Date:  2010-12-15       Impact factor: 25.083

4.  Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

Authors:  Marta Martín-Llahí; Marie-Noëlle Pépin; Mónica Guevara; Fernando Díaz; Aldo Torre; Alberto Monescillo; Germán Soriano; Carlos Terra; Emilio Fábrega; Vicente Arroyo; Juan Rodés; Pere Ginès
Journal:  Gastroenterology       Date:  2008-02-14       Impact factor: 22.682

Review 5.  Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

Authors:  V Arroyo; P Ginès; A L Gerbes; F J Dudley; P Gentilini; G Laffi; T B Reynolds; H Ring-Larsen; J Schölmerich
Journal:  Hepatology       Date:  1996-01       Impact factor: 17.425
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.